Gynaecological cancers
77 results
1 - 77
Gynaecological cancers 
Interventions to improve psychosexual function in women treated for gynaecological cancers- Perioperative enhanced recovery programmes for women with gynaecological cancers
- Centralisation of services for gynaecological cancer
- Exenterative surgery for recurrent gynaecological malignancies
- Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
- Female sexual disorders
- Patient‐reported outcome measures for follow‐up after gynaecological cancer treatment
- Endometriosis
- Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer
- Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer
- Lynch syndrome
- Gynaecological ultrasound examination
- Lichen sclerosus
- Management of drainage for malignant ascites in gynaecological cancer
- Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies
- Abnormal menstrual bleeding
- Laparoscopy versus laparotomy for FIGO stage I ovarian cancer
- Robot‐assisted surgery in gynaecology
- Follow‐up protocols for women with cervical cancer after primary treatment
- Eosinophilia
- Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma
- Lymphadenectomy or sentinel node biopsy for the management of endometrial cancer
- Surgical treatment of stage IA2 cervical cancer
- Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
- Perioperative nutrition interventions for women with ovarian cancer
- Epidermal growth factor receptor blockers for the treatment of ovarian cancer
- Oral contraceptives and the risk of ovarian cancer
- Green tea (Camellia sinensis) for the prevention of cancer
- Interventions for sexual dysfunction following treatments for cancer in women
- Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations
- Chemotherapy for metastatic and recurrent cervical cancer
- Tamoxifen for relapse of ovarian cancer
- Contraception in patients with systemic diseases
- Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease
- Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer
- Pre‐treatment surgical para‐aortic lymph node assessment in locally advanced cervical cancer
- Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer
- Benign gynaecological lesions and tumours
- Antigen‐specific active immunotherapy for ovarian cancer
- Maintenance chemotherapy for ovarian cancer
- Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
- Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women
- Dietary interventions for adult cancer survivors
- Interval brain imaging for adults with cerebral glioma
- Short versus long duration infusions of paclitaxel for any advanced adenocarcinoma: Cochrane systematic review
- Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
- Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer
- Metformin for endometrial hyperplasia